Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion type Assertion NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_head.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion description "[A significantly stronger protective effect is observed when the EPHX1, NQO1, and MPO variant genotypes are combined suggesting that, CYP2D6 polymorphisms may play a role in the susceptibility to pediatric ALL, whereas the EPHX1, NQO1, and MPO polymorphisms might have a protective function against leukemogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_provenance.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion evidence source_evidence_literature NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_provenance.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion SIO_000772 19593802 NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_provenance.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion wasDerivedFrom befree-20140225 NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_provenance.
- NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_assertion wasGeneratedBy ECO_0000203 NP907191.RAx9o3iw7zQvu6MgBvqsIrRItm2U8gkr25bbDE2KQ4f4g130_provenance.